Biotech startup Ahammune Biosciences has raised $5 Mn (about INR 41 Cr) in its Series A round led by pi Ventures.

In addition to vitiligo, Mini also works with cancer survivors, helping to reconstruct areolas post-mastectomy, and individuals with burn scars or surgical marks. Her approach is deeply personal, ...

China Medical System Holdings Limited (the “Company”, together with its subsidiaries, the “Group” or “CMS”) is pleased to announce that on September 24, 2024, the New Drug Application (NDA) for ...

The funding will enable the company in conducting Phase II human clinical trials for its potential drug candidate for ...

The biotech startup will use the funds to assist its Phase II human clinical trials for its drug candidate for vitiligo.

Vitiligo is believed to be an autoimmune condition where the body attacks its own healthy melanin-producing skin cells by mistake. It may be hereditary or triggered by a particular event like ...

Ahammune Biosciences, a clinical-stage therapeutics company focused on developing new treatments for skin diseases, has ...

Janet Jackson is being called “irrelevant” and a “leech” after she questioned Kamala Harris’ race in an interview with the ...

Aesthetic procedures like permanent makeup are usually deemed as “kaartehan” (vanity), but according to Kristine Lucas, a ...

FWAAA posted a video in mid-September featuring 4-year-old Leo as a dog ready to be adopted. The staff there has gotten to know Leo well and say that he gets along with everybody from dogs to cats, to ...

Vitiligo causes patches of skin with lost pigment, but it can also raise your risk of eye and skin damage from UV rays. Find out how new and old treatments may work for your vitiligo.